Abiopharma

🔍 DENAULT LEO P (Director)

Company: PG&E Corp (PCG)

Report Date: 2026-03-31

Detailed Transactions and Holdings:

• Acquired 1,850 shares of Phantom Stock (Derivative)
  Date: 2026-03-31 | Code: A | equity_swap_involved: 0 | shares_owned_after: 9,012.03 | transaction_form_type: 4 | Footnotes: F1, F2, F1, F1, F3

Footnotes:

• F1: Each share of phantom stock is the economic equivalent of one share of common stock and becomes payable in cash upon the reporting person's termination of service as a director.
• F2: Phantom stock acquired upon deferral of compensation under the Deferred Compensation Plan for Non-Employee Directors, exempt under Rule 16b-3(d).
• F3: This total includes 22.62 units of phantom stock acquired on 1/15/2026 pursuant to a dividend reinvestment feature of the Deferred Compensation Plan for Non-Employee Directors.